BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28130475)

  • 21. Breast cancer: Updated screening guidelines - much ado about small improvements.
    Jørgensen KJ; Gøtzsche PC
    Nat Rev Clin Oncol; 2016 Mar; 13(3):139-40. PubMed ID: 26718110
    [No Abstract]   [Full Text] [Related]  

  • 22. Breast cancer screening for women at high risk: review of current guidelines from leading specialty societies.
    Onishi N; Kataoka M
    Breast Cancer; 2021 Nov; 28(6):1195-1211. PubMed ID: 32959120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
    Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
    Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer screening: why, when, and how many?
    Gemignani ML
    Clin Obstet Gynecol; 2011 Mar; 54(1):125-32. PubMed ID: 21278511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?
    McWilliams L; Woof VG; Donnelly LS; Howell A; Evans DG; French DP
    BMC Cancer; 2021 May; 21(1):637. PubMed ID: 34051753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Do unto others as you would have them do unto you": breast imagers' perspectives regarding screening mammography for others and for themselves--do they practice what they preach?
    Lee J; Gordon PB; Whitman GJ
    AJR Am J Roentgenol; 2015 Jun; 204(6):1336-44. PubMed ID: 26001246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is It the Era for Personalized Screening?
    Saccarelli CR; Bitencourt AGV; Morris EA
    Radiol Clin North Am; 2021 Jan; 59(1):129-138. PubMed ID: 33222994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening Guidelines Update for Average-Risk and High-Risk Women.
    Lee CS; Monticciolo DL; Moy L
    AJR Am J Roentgenol; 2020 Feb; 214(2):316-323. PubMed ID: 31714845
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of screening mammography in the era of modern breast cancer treatment.
    Miller AB
    Climacteric; 2018 Jun; 21(3):204-208. PubMed ID: 29338480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening Mammography for Women in Their 40s: The Potential Impact of the American Cancer Society and U.S. Preventive Services Task Force Breast Cancer Screening Recommendations.
    Pitman JA; McGinty GB; Soman RR; Drotman MB; Reichman MB; Arleo EK
    AJR Am J Roentgenol; 2017 Sep; 209(3):697-702. PubMed ID: 28504572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practice Bulletin No. 179 Summary: Breast Cancer Risk Assessment and Screening in Average-Risk Women.
    Obstet Gynecol; 2017 Jul; 130(1):241-243. PubMed ID: 28644328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: a case-control study.
    Winkel RR; von Euler-Chelpin M; Nielsen M; Petersen K; Lillholm M; Nielsen MB; Lynge E; Uldall WY; Vejborg I
    BMC Cancer; 2016 Jul; 16():414. PubMed ID: 27387546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.
    Lee CH; Dershaw DD; Kopans D; Evans P; Monsees B; Monticciolo D; Brenner RJ; Bassett L; Berg W; Feig S; Hendrick E; Mendelson E; D'Orsi C; Sickles E; Burhenne LW
    J Am Coll Radiol; 2010 Jan; 7(1):18-27. PubMed ID: 20129267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alignment of breast cancer screening guidelines, accountability metrics, and practice patterns.
    Onega T; Haas JS; Bitton A; Brackett C; Weiss J; Goodrich M; Harris K; Pyle S; Tosteson AN
    Am J Manag Care; 2017 Jan; 23(1):35-40. PubMed ID: 28141929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for Breast Cancer: What You Need to Know.
    Farrell K; Bennett DL; Schwartz TL
    Mo Med; 2020; 117(2):133-135. PubMed ID: 32308238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women.
    Obstet Gynecol; 2017 Jul; 130(1):e1-e16. PubMed ID: 28644335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Changes to Breast Cancer Screening Guidelines on Healthcare Providers and Patients.
    Hartnett E
    Clin J Oncol Nurs; 2016 Apr; 20(2):203-5. PubMed ID: 26991715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.
    Onega T; Beaber EF; Sprague BL; Barlow WE; Haas JS; Tosteson AN; D Schnall M; Armstrong K; Schapira MM; Geller B; Weaver DL; Conant EF
    Cancer; 2014 Oct; 120(19):2955-64. PubMed ID: 24830599
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.